Produced in partnership with IBTV, our Roving Reporter series captures real-time perspectives from across the life sciences industry. Filmed on the floor at ARM’s Meeting on the Med 2026 in Rome, this episode brings together leading voices from across cell and gene therapy to ask how close the sector is to overcoming the manufacturing challenges that continue to limit scale, consistency, and patient access.
Advanced therapy production remains complex, costly, and difficult to standardize, particularly in autologous cell therapy, where every patient represents a separate manufacturing run. Industry leaders argue that greater automation and digitization will be essential to reducing manual intervention, controlling variability, and making processes more repeatable across sites and patient populations.
Featuring insights from Miguel Forte of Kiji Therapeutics, Susan Nichols of Propel Biosciences, Josh Ludwig of ScaleReady, Jason Foster of Ori Biotech, Alexa Crăciunescu of Autolomous, and Louis Cicchini of Cencora, the discussion explores how closed systems, digital infrastructure, real-time analytics, and AI-enabled automation are reshaping advanced therapy manufacturing.
Watch the video below.
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
